Response of brain metastases from lung cancer to systemic chemotherapy with carboplatin and etoposide

Oncology (Switzerland)

Volumn 53, Issue 3, 1996, Pages 210-213

  Malacarne, Paolo ^a   Santini, Alessandra ^a   Maestri, Antonio ^a  

^a S ANNA HOSPITAL   (Italy)

Author keywords

Brain metastases; Chemotherapy; Lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETOPOSIDE; PLATINUM DERIVATIVE;

ADULT; AGED; ALOPECIA; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW APLASIA; BONE MARROW TOXICITY; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; LEUKOPENIA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; NEPHROTOXICITY; NEUROTOXICITY; PNEUMONIA; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOPHLEBITIS;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 0029971391     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227562     Document Type: Article

References (20)

1. Rizzi A, Tondini M, Rocco G, Rossi G, et al: Lung cancer with a single brain metastasis: Therapeutic options, Tumor Tumori 1990;76: 579-581.
2. Kristenscn CA, Kristjansen PEG, Hansen HH: Systemic chemotherapy of brain métastases from small-cell lung cancer: A review, J Clin Oncol 1992;10:1498-1502.
3. Tsukada Y, Fouad A, Pickrcn JWW, Warren WL: Central nervous system métastases from breast carcinoma, An autopsy study, Cancer 1983;52:2349-2354.
4. Siegers HP: Chemotherapy for brain métastases: Recent developments and clinical considerations, CancerTreat Rev 1990;17:63-76.
5. Rail DP, Zubrod CG: Mechanisms of drug absorption and excretion: Passage of drugs in and out of the central nervous system, Annu Rev Pharmacol 1962;2:109-128.
6. Boogerd W, Dalesio O, Bais EM, Van der Sande JJ: Response of brain métastasés from breast cancer to systemic chemotherapy, Cancer 1992;69:972-980.
7. Santini A, Malacarnc P, Maestri A, Indelli M: Combination chemotherapy with carboplatin and etoposide of brain métastasés from cancer, Eur J Canacer 1994;30:322-323.
8. Cocconi G, Lottici R, Bisagni G, Bacchi M, ct al: Combination therapy with platinum and etoposide of brain métastasés from breast carcinoma, Cancer Invest 1990:9:327-334.
9. Groen HJM, Smit EF, Haaxma-Reiche H, Pos-trus PE: Carboplatin as second line treatment for recurrent or progressive brain métastasés from small cell lung cancer, Eur J Cancer 1993; 29:1696-1699.
10. Rustin GJS, Newlands ES, Bagshawe KD: Successful management of metastatic and primary' germ cell tumors in the brain, Cancer 1986;57: 2108-2113.
11. Doz F, Berens ME, Dougherty DV, Rosenblum ML: Comparison of the cytotoxic activities of cisplatin and carboplatin against glioma cell lines at pharmacologically relevant drug exposure, J Neurol Oncol 1991:11:27-35.
12. Siddik ZH, Jones M, Boxall FE, Harrap KR: Comparative distribution of carboplatin and cisplatin in mice, Cancer Chemother Pharmacol 1988;21:19-24.
13. Yarbro JW, Bornstein RS, Mastrangelo MJ: Carboplatin (JM-8) update: Current perspective and future directions, Semin Oncol 1992; 19(suppl 2)
14. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment, Cancer 1981;47:207-214.
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations, J Am Stat Assoc 1958:53:457-480.
16. Rosner D: Chemotherapy in brain metastases; in Anies FC, Blumenschein SR, Montague ED (eds): Current Controversies in Breast Cancer, Austin, University of Texas Press, 1984. pp 487-494.
17. Fewer D: Phase II study of l,2(chloroethyl)-3-cyclohexyl- 1-nitrosourea (CCNU-79037) in the treatment of brain tumors, Cancer Chemother Rep 1972;56:421-427.
18. Rosier D, Nemoto T, Lane WW: Chemotherapy induces regression of brain metastases in breast carcinoma, Cancer 1986:58:832-839.
19. Zucchetti M, Rossi C, Knerich R, Donelli MG, et al: Concentrations of VP 16 and VM26 in human brain tumours, Ann Oncol 1991:2.63-66.
20. Stewart DJ, Leavens M, Maor M: Human central nervous system distribution of m-diam-minc-dichloroplatinum and use as a radiosensitizer in malignant brain tumours, Cancer Res 1982:42:2474-2479